Acadian Asset Management’s AnaptysBio ANAB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$730K Buy
13,219
+7,410
+128% +$399K ﹤0.01% 1258
2025
Q4
$280K Buy
+5,809
New +$226K ﹤0.01% 1450
2024
Q4
Sell
-633
Closed -$21K 1615
2024
Q3
$21K Buy
+633
New +$21.6K ﹤0.01% 1970
2024
Q2
Sell
-18,671
Closed -$420K 1738
2024
Q1
$420K Buy
+18,671
New +$442K ﹤0.01% 1051
2022
Q2
Sell
-152,885
Closed -$3.78M 1670
2022
Q1
$3.78M Sell
152,885
-37,265
-20% -$1.13M 0.02% 523
2021
Q4
$6.6M Buy
190,150
+13,496
+8% +$428K 0.02% 400
2021
Q3
$4.79M Buy
176,654
+15,270
+9% +$388K 0.02% 457
2021
Q2
$4.18M Buy
161,384
+17,007
+12% +$408K 0.02% 512
2021
Q1
$3.11M Buy
144,377
+26,601
+23% +$671K 0.01% 615
2020
Q4
$2.53M Sell
117,776
-24,547
-17% -$596K 0.01% 693
2020
Q3
$2.1M Buy
142,323
+19,341
+16% +$349K 0.01% 654
2020
Q2
$2.75M Buy
+122,982
New +$2.25M 0.01% 644

Other funds holding ANAB